Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12512 | 30414175 | J Sci Food Agric | Triticum aestivum ethanolic extract improves non-alcoholic fatty liver disease in mice fed a choline-deficient or high-fat diet. | 2019 | Details |
| A12514 | 30413050 | Pharmaceuticals (Basel) | Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once? | 2018 | Details |
| A12520 | 30411690 | Curr Comput Aided Drug Des | Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors. | 2019 | Details |
| A12522 | 30411515 | Clin Obes | Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity. | 2018 | Details |
| A12527 | 30409703 | Mol Metab | Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis. | 2018 | Details |
| A12533 | 30405551 | Front Microbiol | Endotoxemia by Porphyromonas gingivalis Injection Aggravates Non-alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice. | 2018 | Details |
| A12535 | 30404689 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Nonalcoholic Fatty Liver Disease and Weight Loss]. | 2018 | Details |
| A12551 | 30394863 | Metab Syndr Relat Disord | Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers. | 2018 | Details |
| A12554 | 30393477 | Arch Med Sci | Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis. | 2017 | Details |
| A12560 | 30391126 | Trends Mol Med | Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism. | 2018 | Details |
| A12561 | 30390352 | J Clin Lab Anal | Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease. | 2018 | Details |
| A12567 | 30388378 | Can J Physiol Pharmacol | Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times. | 2018 | Details |
| A12569 | 30387292 | J Diabetes Investig | Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men. | 2018 | Details |
| A12577 | 30381838 | J Physiol | SIRT1 overexpression attenuates offspring metabolic and liver disorders as a result of maternal high-fat feeding. | 2018 | Details |
| A12578 | 30380656 | Nutrients | Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12582 | 30378562 | Biomed Khim | [Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity]. | 2018 | Details |
| A12587 | 30374976 | J Pathol | Does prenylation predict progression in NAFLD? | 2018 | Details |
| A12588 | 30374329 | Front Endocrinol (Lausanne) | Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. | 2018 | Details |
| A12590 | 30373519 | BMC Cardiovasc Disord | The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study. | 2018 | Details |
| A12592 | 30372785 | Hepatology | Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis. | 2019 | Details |
| A12595 | 30369883 | Front Physiol | Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity. | 2018 | Details |
| A12596 | 30369082 | J Diabetes Investig | Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis. | 2018 | Details |
| A12612 | 30364513 | J Med Life | The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease. | 2018 | Details |
| A12614 | 30363715 | Mediators Inflamm | Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy. | 2018 | Details |
| A12622 | 30360708 | Mini Rev Med Chem | Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables. | 2019 | Details |
| A12625 | 30360555 | Nutrients | Cafeteria Diet Feeding in Young Rats Leads to Hepatic Steatosis and Increased Gluconeogenesis under Fatty Acids and Glucagon Influence. | 2018 | Details |
| A12628 | 30360437 | Int J Mol Sci | Dietary Isoliquiritigenin at a Low Dose Ameliorates Insulin Resistance and NAFLD in Diet-Induced Obesity in C57BL/6J Mice. | 2018 | Details |
| A12630 | 30359962 | Pharmacol Res | Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2018 | Details |
| A12631 | 30359371 | PLoS One | N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice. | 2018 | Details |
| A12639 | 30355853 | J Biomed Res | Non-alcoholic fatty liver disease: a narrative review of genetics. | 2018 | Details |
| A12640 | 30355361 | Lipids Health Dis | Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease. | 2018 | Details |
| A12647 | 30349997 | Sleep Breath | The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea. | 2018 | Details |
| A12649 | 30347674 | Nutrients | Effects of Unfiltered Coffee and Bioactive Coffee Compounds on the Development of Metabolic Syndrome Components in a High-Fat-/High-Fructose-Fed Rat Model. | 2018 | Details |
| A12652 | 30346875 | Metab Syndr Relat Disord | Growth Hormone Deficiency and Nonalcoholic Fatty Liver Disease with Insights from Humans and Animals: Pediatric Implications. | 2018 | Details |
| A12656 | 30344430 | J Ginseng Res | Ginseng seed oil ameliorates hepatic lipid accumulation in vitro and in vivo. | 2017 | Details |
| A12658 | 30343320 | Cell Mol Life Sci | Molecular pathways of nonalcoholic fatty liver disease development and progression. | 2018 | Details |
| A12660 | 30341231 | Postgrad Med J | Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. | 2018 | Details |
| A12663 | 30338914 | J Cell Mol Med | MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling. | 2018 | Details |
| A12664 | 30338761 | Gen Physiol Biophys | Effect of metabolic syndrome on neural plasticity and morphology of the hippocampus: correlations of neurological deficits with physiological status of the rat. | 2018 | Details |
| A12665 | 30338118 | Obes Sci Pract | Efficacy of canagliflozin against nonalcoholic fatty liver disease: a prospective cohort study. | 2018 | Details |
| A12697 | 30323574 | Clin Interv Aging | Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. | 2018 | Details |
| A12700 | 30323174 | Eur J Clin Nutr | Determinants of ectopic liver fat in metabolic disease. | 2018 | Details |
| A12713 | 30317984 | Curr Pharm Des | The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors. | 2018 | Details |
| A12722 | 30315891 | Diabetes Metab | Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. | 2018 | Details |
| A12728 | 30314557 | Maturitas | Moderate to severe vasomotor symptoms are risk factors for non-alcoholic fatty liver disease in postmenopausal women. | 2018 | Details |
| A12733 | 30312513 | Liver Int | Potential mechanisms linking gut microbiota and portal hypertension. | 2018 | Details |
| A12734 | 30312023 | Anat Rec (Hoboken) | Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12739 | 30309516 | Metabolism | Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1. | 2018 | Details |
| A12753 | 30300835 | J Nutr Biochem | Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice. | 2018 | Details |
| A12754 | 30300671 | Biochim Biophys Acta Mol Basis Dis | Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice. | 2018 | Details |
| A12758 | 30299993 | Expert Opin Pharmacother | Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease. | 2018 | Details |
| A12759 | 30298849 | J Toxicol Sci | Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats. | 2018 | Details |
| A12763 | 30298568 | Liver Int | Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease. | 2018 | Details |
| A12774 | 30293065 | Ann Nutr Metab | Cholesteryl Ester Transfer Protein Variant (RS1800777) with Liver Histology in Non-Alcoholic Fatty Liver Disease Patients. | 2018 | Details |
| A12778 | 30292107 | J Nutr Biochem | Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. | 2018 | Details |
| A12799 | 30283242 | Am J Lifestyle Med | Prevention of Diabetes: Countless Opportunities and Clear Challenges. | 2017 | Details |
| A12801 | 30282916 | Diseases | Anti-Diabetic Medications for the Pharmacologic Management of NAFLD. | 2018 | Details |
| A12806 | 30275422 | Int J Mol Sci | Hepatoprotective Effect of Loquat Leaf Flavonoids in PM2.5-Induced Non-Alcoholic Fatty Liver Disease via Regulation of IRs-1/Akt and CYP2E1/JNK Pathways. | 2018 | Details |
| A12823 | 30266576 | Diabetes Metab | Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach. | 2018 | Details |
| A12830 | 30264828 | AIDS Rev | Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection | 2018 | Details |
| A12836 | 30261661 | Int J Mol Sci | Fc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis. | 2018 | Details |
| A12838 | 30261289 | Biochim Biophys Acta Mol Basis Dis | Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans. | 2018 | Details |
| A12847 | 30257974 | Diabetes | Insulin Resistance and Vulnerability to Cardiac Ischemia. | 2018 | Details |
| A12863 | 30250238 | Sci Rep | Human hepatic 3D spheroids as a model for steatosis and insulin resistance. | 2018 | Details |
| A12875 | 30247335 | Nurs Res | Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12877 | 30246507 | Helicobacter | Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma? | 2018 | Details |
| A12880 | 30244573 | J Agric Food Chem | Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12920 | 30227635 | Nutrients | Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation. | 2018 | Details |
| A12922 | 30226474 | J Clin Invest | Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition. | 2018 | Details |
| A12923 | 30225267 | J Diabetes Res | Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats. | 2018 | Details |
| A12926 | 30222981 | Toxicol Appl Pharmacol | Met-enkephalin improves metabolic syndrome in high fat diet challenged mice through promotion of adipose tissue browning. | 2018 | Details |
| A12942 | 30214535 | Exp Ther Med | Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. | 2018 | Details |
| A12943 | 30214501 | Diabetol Metab Syndr | Characterization of spontaneously-developed non-alcoholic fatty liver disease in aged rhesus monkeys. | 2018 | Details |
| A12951 | 30212963 | Medicine (Baltimore) | Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials. | 2018 | Details |
| A12957 | 30208901 | Lipids Health Dis | Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease. | 2018 | Details |
| A12958 | 30208604 | Molecules | Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line. | 2018 | Details |
| A12960 | 30208301 | Food Chem Toxicol | Trigonelline prevents high cholesterol and high fat diet induced hepatic lipid accumulation and lipo-toxicity in C57BL/6J mice, via restoration of hepatic autophagy. | 2018 | Details |
| A12962 | 30206761 | Hepatol Int | Metabolic effects of reduced growth hormone action in fatty liver disease. | 2018 | Details |
| A12974 | 30201044 | Biol Sex Differ | Sex-specific differences in hepatic steatosis in obese spontaneously hypertensive (SHROB) rats. | 2018 | Details |
| A12975 | 30200724 | Zhongguo Zhong Yao Za Zhi | [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. | 2018 | Details |
| A12978 | 30200408 | Nutrients | Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease. | 2018 | Details |
| A12985 | 30196282 | Cell Physiol Biochem | Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF. | 2018 | Details |
| A12988 | 30194708 | Aliment Pharmacol Ther | Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. | 2018 | Details |
| A12994 | 30191231 | Analyst | Rapid diagnostics of liver steatosis by Raman spectroscopy via fiber optic probe: a pilot study. | 2018 | Details |
| A12996 | 30190738 | Pak J Med Sci | Association of serum liver enzyme Alanine Aminotransferase (ALT) in patients with type 2 diabetes. | 2022 | Details |
| A13004 | 30185840 | Eur J Clin Nutr | Body composition and insulin resistance in children. | 2018 | Details |
| A13006 | 30185098 | J Int Med Res | Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups. | 2018 | Details |
| A13008 | 30183204 | Neuro Endocrinol Lett | Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases. | 2018 | Details |
| A13009 | 30183139 | Mol Nutr Food Res | Gamma-Tocotrienol Attenuates the Hepatic Inflammation and Fibrosis by Suppressing Endoplasmic Reticulum Stress in Mice. | 2018 | Details |
| A13010 | 30182761 | Endocr Res | A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities. | 2018 | Details |
| A13021 | 30178233 | Front Med | Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. | 2018 | Details |
| A13028 | 30174213 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. | 2018 | Details |
| A13033 | 30171810 | Horm Mol Biol Clin Investig | Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis. | 2018 | Details |
| A13042 | 30168806 | J Clin Invest | Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease. | 2018 | Details |
| A13043 | 30166956 | Gastroenterol Hepatol (N Y) | Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13044 | 30166861 | World J Gastroenterol | C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. | 2018 | Details |
| A13076 | 30148144 | World J Clin Cases | PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. | 2018 | Details |
| A13079 | 30145577 | Ann Hepatol | Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats. | 2018 | Details |
| A13100 | 30138985 | Zhonghua Yi Xue Za Zhi | [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes]. | 2018 | Details |
| A13106 | 30135638 | Cent Eur J Immunol | Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. | 2018 | Details |